Advanced wound care dressings have a significant impact on the total cost of care. This is essential since chronic wounds affect roughly 6.5 million individuals and cost up to $25 billion per year to treat. Wound dressing formulations are frequently classified as medical devices rather than drugs, depending on the plan design.
Several factors are driving the increased need for wound care, including the rising frequency of chronic diseases like diabetes, cancer, and autoimmune disorders; the predicted increase in surgical operations; and a greater focus on reducing hospital stays.
All clinical care settings, struggle to minimize costs under a single reimbursement system. However, simplified while maintaining high-quality care. Implementing a cost-cutting strategy can be achieved by using a manufacturer. Identifying your facility’s goals, evaluating your wound care formulary, and collaborating with a vendor who can meet all of your skincare and wound dressing needs will help you maintain wound management costs as low as possible.
How Manufacturers Can Support Your Practice or Facility Cost Containment
The most significant information is that the product’s manufacturer is an expert. Furthermore, manufacturers are involved in every stage of design and production, so they are familiar with every element and feature of a product. They offer the greatest guidance to each customer looking to make a purchase that meets their needs. When you go to a manufacturer to acquire a product, you are looking for specialist assistance as well as a variety of selections from a wide range of products.
Setting Goals in Your Facility of Private Practice
Human BioSciences, Inc. USA is customer-driven manufacturing of medical-grade pharmaceuticals wound care solutions, and non-prescription consumer products. HBS’ manufacturing expertise has made the company the lowest cost manufacturer of collagen wound care products in existence.
Consumers incur considerable, unneeded out-of-pocket expenses as a result of these and similar items. Patients with active wounds, particularly those with high-deductible health plans, may postpone or avoid using these products completely because of their high cost. They may be more susceptible to infections, scars, and a longer healing period as a result of this. Sponsors of plans are also impacted. Wound care goods with a high price tag are a subset of a larger financial exposure to high-priced, low-value products on the market.
We’ve designed, developed, and operated state-of-the-art collagen and other product manufacturing facilities all over the world. FDA CGMP current revision, ISO 13485, and Drug Controller of India medical device standards are all met at our facilities.
Human BioSciences, Inc. blog offers education and tips; however,the information provided by this website or company is not a substitute for medical treatment or advice.
Mrs. Vann is responsible for branding, design, and public outreach efforts for the company. Mrs. Vann has over five years of experience in the creative design arena. She has spearheaded multiple marketing campaigns, both domestic and international. She also has experience producing several television and live-stage programs. She has a Bachelor’s Degree in Film and Video Studies from George Mason University.
Mr. Patel is the Vice President of Operations for Human BioSciences. As such, he is responsible for strategy development for optimal growth, organizing multiple teams and implementing optimal product delivery for the growth of HBS. He has served multiple positions within HBS since 2001, including Operations Manager. With an MBA in Pharmaceutical Healthcare and a Bachelor’s in Pharmaceuticals, Mr. Patel brings deep technical knowledge in collagen product production with a rich history in managing teams.
As the President of Human BioSciences, Dr. Rohan K Jain is responsible for the company’s overall operations, with a focus on research and development. Dr. Jain has supervised and conducted extensive research in the collagen, biomaterials, and protein space, resulting in the release of numerous new products to the market. Prior to his role at HBS, Dr. Jain was a capital markets attorney at Shearman & Sterling LLP. He received his Doctorate in Law and his MBA from New York University; his Bachelor’s degrees in Biomedical Engineering and Materials Science and his Master’s in Engineering Management from Johns Hopkins University. He is a member of the New York and Maryland bars.
Cheryl Carver, LPN, WCC, CWCA, CWCP, DAPWCA, FACCWS is responsible for clinical education and training initiatives for customer accounts. Ms. Carver has amassed a wealth of clinical knowledge and industry experience in her more than 20 years as a board-certified wound care nurse. She has authored over 200 published white papers, ebooks, blogs, and articles for WoundSource and freelance.
Dr. Goebel is responsible for the company’s physical infrastructure and global expansion efforts through partnerships. Prior to joining HBS, Dr. Goebel was Managing Director at the Graf Matuschka Group in Munich, Germany, where he was actively involved in restructuring and privatization in East Germany and Eastern Europe. He was also a member of the American group of the EBRD European Bank for Reconstruction and Development in the privatization of the Russian economy and military complex. He has over forty years’ experience in many different industries including medical devices, pharmacy, and others. Dr. Goebel earned his Doctorate and Postdoctoral degrees in Economics in East Berlin.
Mr. Kumar is responsible for the company’s overall accounting and finance activities with a focus on internal control and taxation.
Mr. Kumar has over 25 years of public and corporate accounting experience. He is a Certified Public Accountant, licensed in the State of Virginia, Maryland, and Washington D.C., and an Enrolled Agent authorized to practice before the Internal Revenue Service. Mr. Kumar is also a Chartered Accountant and fellow member of the Institute of Chartered Accountants of India. Mr. Kumar received his Master’s degree in Commerce from Himalayan University in India.
Mr. Slovick is responsible for all regulatory and quality affairs in the company. Mr. Slovick has worked in regulatory, quality, and clinical services within the medical device and diagnostics industry for nearly 40 years. He founded Methodize Inc., to offer strategic support for approval of medical devices and in vitro diagnostics products. Mr. Slovick has a Bachelor’s degree in Management Information Systems.
Mr. Agarwal is responsible for Corporate Business Development, Sales, and Product Development, both locally and internationally for the company. Mr. Agarwal has over six years of corporate sales and business development experience. He completed his Master of Science in Engineering Management degree from Johns Hopkins University with a technical concentration in Mechanical Engineering. In the past, he has also worked as a fundraising volunteer for three years and thus gained insights in community fundraising and business development. Additionally, he has interned at a manufacturing firm and understood various intricacies involved in manufacturing ranging from the floor level to the supply chain. He has published a paper on Omni Channel Supply Chain and is a certified Lean Six Sigma associate. He has also interned as a business development consultant to a startup for market research and pricing strategies in Israel. Equipped with a combination of management and technical background acquired from his diverse experiences and education, he is perfectly suited to lead the business development efforts for Human BioSciences.
